No abstract available
MeSH terms
-
Aged
-
Female
-
Glucagon-Like Peptides* / adverse effects
-
Glucagon-Like Peptides* / therapeutic use
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / therapeutic use
-
Male
-
Middle Aged
-
Optic Neuropathy, Ischemic* / chemically induced
-
Optic Neuropathy, Ischemic* / diagnosis
-
Optic Neuropathy, Ischemic* / drug therapy
-
Visual Acuity
Substances
-
semaglutide
-
Glucagon-Like Peptides
-
Hypoglycemic Agents